ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,095,000 | -12.8% | 168,431 | -4.0% | 0.01% | -10.0% |
| Q3 2016 | $2,403,000 | +107.3% | 175,528 | +11.9% | 0.01% | +100.0% |
| Q2 2016 | $1,159,000 | +64.2% | 156,798 | +45.7% | 0.01% | +66.7% |
| Q1 2016 | $706,000 | +1.9% | 107,627 | -2.9% | 0.00% | 0.0% |
| Q4 2015 | $693,000 | +9.3% | 110,836 | +2.1% | 0.00% | 0.0% |
| Q3 2015 | $634,000 | -29.4% | 108,606 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $898,000 | -9.7% | 108,606 | -10.1% | 0.00% | 0.0% |
| Q1 2015 | $995,000 | +15.6% | 120,749 | -3.6% | 0.00% | 0.0% |
| Q4 2014 | $861,000 | +25.1% | 125,279 | -1.6% | 0.00% | +33.3% |
| Q3 2014 | $688,000 | -15.0% | 127,335 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $809,000 | +1271.2% | 127,046 | +1360.3% | 0.00% | – |
| Q4 2013 | $59,000 | -97.5% | 8,700 | -93.3% | 0.00% | -100.0% |
| Q3 2013 | $2,396,000 | +9.0% | 130,200 | +3.6% | 0.01% | -8.3% |
| Q2 2013 | $2,198,000 | – | 125,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |